{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:59:45Z","timestamp":1790207985581,"version":"4.1.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"40","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,10,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Breast cancer (BC) recurrence remains a major clinical challenge, leaving patients in perpetual uncertainty about disease relapse after primary treatment. BC dormancy, an adaptive survival state of disseminated tumour cells, is a key driver of both early and late recurrence. However, the mechanisms regulating BC dormancy remain poorly understood. Emerging evidence suggests that tumour hypoxia, extracellular matrix (ECM) remodelling, and therapy-induced stress drive dormancy by altering cellular metabolism, gene expression, and immune interactions, enabling long-term survival of dormant BC cells. With no dormancy-specific therapies currently approved, a deeper understanding of dormancy-associated survival mechanisms is crucial for identifying therapeutic targets and developing strategies to eradicate dormant BC cells, thereby preventing recurrence and improving patient outcomes. This review comprehensively examines major dormancy-inducing factors and the adaptive survival mechanisms of dormant BC cells. We also highlight critical gaps in preclinical models that hinder the translation of preclinical cancer dormancy insights into clinical applications and propose potential therapeutic strategies to prevent BC recurrence.<\/jats:p>","DOI":"10.1038\/s41388-025-03529-3","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:14:50Z","timestamp":1756278890000},"page":"3759-3773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Decoding the adaptive survival mechanisms of breast cancer dormancy"],"prefix":"10.1038","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-2746","authenticated-orcid":false,"given":"Francis M.","family":"Barnieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaitan","family":"Olanrewaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif F.","family":"El-Khamisy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"3529_CR1","unstructured":"G. 2022, Estimated cancer incidence, mortality and prevalence worldwide in 2022, https:\/\/gco.iarc.fr\/en."},{"key":"3529_CR2","unstructured":"CRUK, Breast cancer statistics https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer."},{"key":"3529_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/jnci\/djab202","volume":"114","author":"RN Pedersen","year":"2022","unstructured":"Pedersen RN, Esen B\u00d6, Mellemkj\u00e6r L, Christiansen P, Ejlertsen B, Lash TL, et al. The incidence of breast cancer recurrence 10-32 years after primary diagnosis. J Natl Cancer Inst. 2022;114:391\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"3529_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","volume":"124","author":"AI Riggio","year":"2021","unstructured":"Riggio AI, Varley KE, Welm AL. The lingering mysteries of metastatic recurrence in breast cancer. Br J Cancer. 2021;124:13\u201326.","journal-title":"Br J Cancer"},{"key":"3529_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40164-015-0028-8","volume":"4","author":"JP Leone","year":"2015","unstructured":"Leone JP, Leone BA. Breast cancer brain metastases: the last frontier. Exp Hematol Oncol. 2015;4:33.","journal-title":"Exp Hematol Oncol"},{"key":"3529_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","volume":"5","author":"A Prat","year":"2011","unstructured":"Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol. 2011;5:5\u201323.","journal-title":"Mol Oncol"},{"key":"3529_CR7","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","volume":"11","author":"R Rouzier","year":"2005","unstructured":"Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin cancer Res. 2005;11:5678\u201385.","journal-title":"Clin cancer Res"},{"key":"3529_CR8","doi-asserted-by":"publisher","first-page":"112935","DOI":"10.1016\/j.ejca.2023.05.023","volume":"189","author":"T Grinda","year":"2023","unstructured":"Grinda T, Antoine A, Jacot W, Cottu P-H, de la Motte Rouge T, Frenel J-S, et al. Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort. Eur J Cancer. 2023;189:112935.","journal-title":"Eur J Cancer"},{"key":"3529_CR9","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, et al. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years. N Engl J Med. 2017;377:1836\u201346.","journal-title":"N Engl J Med"},{"key":"3529_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/jso.2930230311","volume":"23","author":"YT Lee","year":"1983","unstructured":"Lee YT. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol. 1983;23:175\u201380.","journal-title":"J Surg Oncol"},{"key":"3529_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10555-023-10096-0","volume":"42","author":"JL Kirkland","year":"2023","unstructured":"Kirkland JL. Tumor dormancy and disease recurrence. Cancer Metastasis Rev. 2023;42:9\u201312.","journal-title":"Cancer Metastasis Rev"},{"key":"3529_CR12","unstructured":"Willis RA. The spread of tumours in the human body, J. & A. Chuchill, London, 1934."},{"key":"3529_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fonc.2018.00072","volume":"8","author":"AS Yadav","year":"2018","unstructured":"Yadav AS, Pandey PR, Butti R, Radharani NNV, Roy S, Bhalara SR, et al. The biology and therapeutic implications of tumor dormancy and reactivation. Front Oncol. 2018;8:72.","journal-title":"Front Oncol"},{"key":"3529_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","volume":"20","author":"TG Phan","year":"2020","unstructured":"Phan TG, Croucher PI. The dormant cancer cell life cycle. Nat Rev Cancer. 2020;20:398\u2013411.","journal-title":"Nat Rev Cancer"},{"key":"3529_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/bmj.2.4888.607","volume":"2","author":"G Hadfield","year":"1954","unstructured":"Hadfield G. The dormant cancer cell. Br Med J. 1954;2:607\u201310.","journal-title":"Br Med J"},{"key":"3529_CR16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/annonc\/mdi352","volume":"16","author":"M Colozza","year":"2005","unstructured":"Colozza M, Azambuja E, Cardoso F, Sotiriou C, Larsimont D, Piccart MJ. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?. Ann Oncol. 2005;16:1723\u201339.","journal-title":"Ann Oncol"},{"key":"3529_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/ncb3465","volume":"19","author":"G Fluegen","year":"2017","unstructured":"Fluegen G, Avivar-Valderas A, Wang Y, Padgen MR, Williams JK, Nobre AR, et al. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nat Cell Biol. 2017;19:120\u201332.","journal-title":"Nat Cell Biol"},{"key":"3529_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01503-5","volume":"24","author":"Q Ren","year":"2022","unstructured":"Ren Q, Khoo WH, Corr AP, Phan TG, Croucher PI, Stewart SA. Gene expression predicts dormant metastatic breast cancer cell phenotype. Breast Cancer Res. 2022;24:10.","journal-title":"Breast Cancer Res"},{"key":"3529_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nm0295-149","volume":"1","author":"L Holmgren","year":"1995","unstructured":"Holmgren L, O\u2019reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149\u201353.","journal-title":"Nat Med"},{"key":"3529_CR20","doi-asserted-by":"publisher","first-page":"720","DOI":"10.4143\/crt.2023.468","volume":"55","author":"HY Min","year":"2023","unstructured":"Min HY, Lee HY. Cellular dormancy in cancer: mechanisms and potential targeting strategies. Cancer Res Treat. 2023;55:720\u201336.","journal-title":"Cancer Res Treat"},{"key":"3529_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","volume":"24","author":"BC Prager","year":"2019","unstructured":"Prager BC, Xie Q, Bao S, Rich JN. Cancer stem cells: the architects of the tumor ecosystem. Cell Stem Cell. 2019;24:41\u201353.","journal-title":"Cell Stem Cell"},{"key":"3529_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu T-S, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488:522\u20136.","journal-title":"Nature"},{"key":"3529_CR23","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.2304","volume":"17","author":"H Clevers","year":"2011","unstructured":"Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med. 2011;17:313\u20139.","journal-title":"Nat Med"},{"key":"3529_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrc3368","volume":"12","author":"P Valent","year":"2012","unstructured":"Valent P, Bonnet D, De Maria R, Lapidot T, Copland M, Melo JV, et al. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer. 2012;12:767\u201375.","journal-title":"Nat Rev Cancer"},{"key":"3529_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrc3184","volume":"12","author":"LV Nguyen","year":"2012","unstructured":"Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells: an evolving concept. Nat Rev Cancer. 2012;12:133\u201343.","journal-title":"Nat Rev Cancer"},{"key":"3529_CR26","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23:1124\u201334.","journal-title":"Nat Med"},{"key":"3529_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM200002243420801","volume":"342","author":"S Braun","year":"2000","unstructured":"Braun S, Pantel K, M\u00fcller P, Janni W, Hepp F, Kentenich CR, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med. 2000;342:525\u201333.","journal-title":"N Engl J Med"},{"key":"3529_CR28","first-page":"148","volume":"12","author":"N Karimi","year":"2020","unstructured":"Karimi N, Oloomi M, Orafa Z. Circulating tumor cells detection in patients with early breast cancer using MACS immunomagnetic flow cytometry. Avicenna J Med Biotechnol. 2020;12:148\u201356.","journal-title":"Avicenna J Med Biotechnol"},{"key":"3529_CR29","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1200\/JCO.2014.56.9327","volume":"32","author":"B Naume","year":"2014","unstructured":"Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, et al. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. J Clin Oncol. 2014;32:3848\u201357.","journal-title":"J Clin Oncol"},{"key":"3529_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrc2375","volume":"8","author":"K Pantel","year":"2008","unstructured":"Pantel K, Brakenhoff RH, Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer. 2008;8:329\u201340.","journal-title":"Nat Rev Cancer"},{"key":"3529_CR31","doi-asserted-by":"crossref","unstructured":"Banys-Paluchowski M, Reinhardt F, Fehm T. Disseminated Tumor Cells and Dormancy in Breast Cancer Progression, In: Pi\u00f1eiro R (Ed.), Circulating Tumor Cells in Breast Cancer Metastatic Disease, Springer International Publishing, Cham, 2020, pp. 35-43.","DOI":"10.1007\/978-3-030-35805-1_3"},{"key":"3529_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41416-021-01327-8","volume":"125","author":"I Krol","year":"2021","unstructured":"Krol I, Schwab FD, Carbone R, Ritter M, Picocci S, De Marni ML, et al. Detection of clustered circulating tumour cells in early breast cancer. Br J Cancer. 2021;125:23\u201327.","journal-title":"Br J Cancer"},{"key":"3529_CR33","doi-asserted-by":"publisher","first-page":"890248","DOI":"10.3389\/fonc.2022.890248","volume":"12","author":"X Shao","year":"2022","unstructured":"Shao X, Jin X, Chen Z, Zhang Z, Chen W, Jiang J, et al. A comprehensive comparison of circulating tumor cells and breast imaging modalities as screening tools for breast cancer in Chinese women. Front Oncol. 2022;12:890248.","journal-title":"Front Oncol"},{"key":"3529_CR34","first-page":"2275","volume":"18","author":"K Ried","year":"2017","unstructured":"Ried K, Eng P, Sali A. Screening for circulating tumour cells allows early detection of cancer and monitoring of treatment effectiveness: an observational study. Asian Pac J Cancer Prev. 2017;18:2275\u201385.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3529_CR35","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1158\/1078-0432.CCR-04-1110","volume":"10","author":"S Meng","year":"2004","unstructured":"Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res. 2004;10:8152\u201362.","journal-title":"Clin Cancer Res"},{"key":"3529_CR36","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1158\/1078-0432.CCR-05-2821","volume":"12","author":"DF Hayes","year":"2006","unstructured":"Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin cancer Res. 2006;12:4218\u201324.","journal-title":"Clin cancer Res"},{"key":"3529_CR37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41571-023-00781-y","volume":"20","author":"R Lawrence","year":"2023","unstructured":"Lawrence R, Watters M, Davies CR, Pantel K, Lu YJ. Circulating tumour cells for early detection of clinically relevant cancer. Nat Rev Clin Oncol. 2023;20:487\u2013500.","journal-title":"Nat Rev Clin Oncol"},{"key":"3529_CR38","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3390\/cancers11101569","volume":"11","author":"ML De Angelis","year":"2019","unstructured":"De Angelis ML, Francescangeli F, Zeuner A. Breast cancer stem cells as drivers of tumor chemoresistance, dormancy and relapse: new challenges and therapeutic opportunities. Cancers (Basel). 2019;11:1569.","journal-title":"Cancers (Basel)"},{"key":"3529_CR39","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/ncb3408","volume":"18","author":"RW Johnson","year":"2016","unstructured":"Johnson RW, Finger EC, Olcina MM, Vilalta M, Aguilera T, Miao Y, et al. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol. 2016;18:1078\u201389.","journal-title":"Nat Cell Biol"},{"key":"3529_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10555-023-10094-2","volume":"42","author":"A Mukherjee","year":"2023","unstructured":"Mukherjee A, Bravo-Cordero JJ. Regulation of dormancy during tumor dissemination: the role of the ECM. Cancer Metastasis Rev. 2023;42:99\u2013112.","journal-title":"Cancer Metastasis Rev"},{"key":"3529_CR41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2111046118","volume":"119","author":"S Bakhshandeh","year":"2022","unstructured":"Bakhshandeh S, Werner C, Fratzl P, Cipitria A. Microenvironment-mediated cancer dormancy: Insights from metastability theory. Proc Natl Acad Sci. 2022;119:e2111046118.","journal-title":"Proc Natl Acad Sci"},{"key":"3529_CR42","doi-asserted-by":"publisher","first-page":"652266","DOI":"10.3389\/fonc.2021.652266","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang H, Wang M, Schmid T, Xin Z, Kozhuharova L, et al. Hypoxia in breast cancer-scientific translation to therapeutic and diagnostic clinical applications. Front Oncol. 2021;11:652266.","journal-title":"Front Oncol"},{"key":"3529_CR43","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41416-021-01630-4","volume":"126","author":"J Tutzauer","year":"2022","unstructured":"Tutzauer J, Sj\u00f6str\u00f6m M, Holmberg E, Karlsson P, Killander F, Leeb-Lundberg LMF, et al. Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up. Br J Cancer. 2022;126:1145\u201356.","journal-title":"Br J Cancer"},{"key":"3529_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.trecan.2016.05.006","volume":"2","author":"EB Rankin","year":"2016","unstructured":"Rankin EB, Nam J-M, Giaccia AJ. Hypoxia: signaling the metastatic cascade. Trends Cancer. 2016;2:295\u2013304.","journal-title":"Trends Cancer"},{"key":"3529_CR45","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.3390\/ijms20174305","volume":"20","author":"E Butturini","year":"2019","unstructured":"Butturini E, Carcereri de Prati A, Boriero D, Mariotto S. Tumor dormancy and interplay with hypoxic tumor microenvironment. Int J Mol Sci. 2019;20:4305.","journal-title":"Int J Mol Sci"},{"key":"3529_CR46","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/jcb.25972","volume":"118","author":"A Carcereri de Prati","year":"2017","unstructured":"Carcereri de Prati A, Butturini E, Rigo A, Oppici E, Rossin M, Boriero D, et al. Metastatic breast cancer cells enter into dormant state and express cancer stem cells phenotype under chronic hypoxia. J Cell Biochem. 2017;118:3237\u201348.","journal-title":"J Cell Biochem"},{"key":"3529_CR47","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1200\/JCO.22.00908","volume":"40","author":"M Lipsyc-Sharf","year":"2022","unstructured":"Lipsyc-Sharf M, de Bruin EC, Santos K, McEwen R, Stetson D, Patel A, et al. Circulating tumor DNA and late recurrence in high-risk hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer. J Clin Oncol. 2022;40:2408\u201319.","journal-title":"J Clin Oncol"},{"key":"3529_CR48","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1158\/0008-5472.CAN-07-5644","volume":"68","author":"M Smid","year":"2008","unstructured":"Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JGM, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008;68:3108\u201314.","journal-title":"Cancer Res"},{"key":"3529_CR49","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s10585-008-9203-1","volume":"25","author":"FC Bidard","year":"2008","unstructured":"Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, Rodrigues M, Di\u00e9ras V, Mignot L, et al. Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse. Clin Exp Metastasis. 2008;25:871\u20135.","journal-title":"Clin Exp Metastasis"},{"key":"3529_CR50","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s42003-021-02648-3","volume":"4","author":"VM Todd","year":"2021","unstructured":"Todd VM, Vecchi LA, Clements ME, Snow KP, Ontko CD, Himmel L, et al. Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner. Commun Biol. 2021;4:1122.","journal-title":"Commun Biol"},{"key":"3529_CR51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s42255-020-0191-z","volume":"2","author":"DB Fox","year":"2020","unstructured":"Fox DB, Garcia NMG, McKinney BJ, Lupo R, Noteware LC, Newcomb R, et al. NRF2 activation promotes the recurrence of dormant tumour cells through regulation of redox and nucleotide metabolism. Nat Metab. 2020;2:318\u201334.","journal-title":"Nat Metab"},{"key":"3529_CR52","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2021.06.004","volume":"78","author":"KK Payne","year":"2022","unstructured":"Payne KK. Cellular stress responses and metabolic reprogramming in cancer progression and dormancy. Semin Cancer Biol. 2022;78:45\u201348.","journal-title":"Semin Cancer Biol"},{"key":"3529_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108105","volume":"32","author":"C Donato","year":"2020","unstructured":"Donato C, Kunz L, Castro-Giner F, Paasinen-Sohns A, Strittmatter K, Szczerba BM, et al. Hypoxia triggers the intravasation of clustered circulating tumor cells. Cell Rep. 2020;32:108105.","journal-title":"Cell Rep"},{"key":"3529_CR54","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature15726","volume":"527","author":"E Piskounova","year":"2015","unstructured":"Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527:186\u201391.","journal-title":"Nature"},{"key":"3529_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12412-1","volume":"10","author":"I Godet","year":"2019","unstructured":"Godet I, Shin YJ, Ju JA, Ye IC, Wang G, Gilkes DM. Fate-mapping post-hypoxic tumor cells reveals a ROS-resistant phenotype that promotes metastasis. Nat Commun. 2019;10:4862.","journal-title":"Nat Commun"},{"key":"3529_CR56","doi-asserted-by":"publisher","first-page":"5509","DOI":"10.3390\/cancers13215509","volume":"13","author":"I Godet","year":"2021","unstructured":"Godet I, Mamo M, Thurnheer A, Rosen DM, Gilkes DM. Post-hypoxic cells promote metastatic recurrence after chemotherapy treatment in TNBC. Cancers (Basel). 2021;13:5509.","journal-title":"Cancers (Basel)"},{"key":"3529_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/gm271","volume":"3","author":"E Favaro","year":"2011","unstructured":"Favaro E, Lord S, Harris AL, Buffa FM. Gene expression and hypoxia in breast cancer. Genome Med. 2011;3:55.","journal-title":"Genome Med"},{"key":"3529_CR58","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1074\/jbc.M010189200","volume":"276","author":"LB Gardner","year":"2001","unstructured":"Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV. Hypoxia inhibits G1\/S transition through regulation of p27 expression*. J Biol Chem. 2001;276:7919\u201326.","journal-title":"J Biol Chem"},{"key":"3529_CR59","doi-asserted-by":"publisher","first-page":"126","DOI":"10.7150\/jca.1.126","volume":"1","author":"L Li","year":"2010","unstructured":"Li L, Lu Y. Inhibition of hypoxia-induced cell motility by p16 in MDA-MB-231 breast cancer cells. J Cancer. 2010;1:126\u201335.","journal-title":"J Cancer"},{"key":"3529_CR60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s43018-021-00291-9","volume":"3","author":"JS Di Martino","year":"2022","unstructured":"Di Martino JS, Nobre AR, Mondal C, Taha I, Farias EF, Fertig EJ, et al. A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nat Cancer. 2022;3:90\u2013107.","journal-title":"Nat Cancer"},{"key":"3529_CR61","doi-asserted-by":"publisher","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","volume":"30","author":"NM Anderson","year":"2020","unstructured":"Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020;30:R921\u2013r925.","journal-title":"Curr Biol"},{"key":"3529_CR62","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1126\/science.7531366","volume":"267","author":"N Boudreau","year":"1995","unstructured":"Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 1995;267:891\u20133.","journal-title":"Science"},{"key":"3529_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32523-6","volume":"13","author":"P Aouad","year":"2022","unstructured":"Aouad P, Zhang Y, De Martino F, Stibolt C, Ali S, Ambrosini G, et al. Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence. Nat Commun. 2022;13:4975.","journal-title":"Nat Commun"},{"key":"3529_CR64","doi-asserted-by":"crossref","unstructured":"Brisson BK, Stewart DC, Dekky B, Berger AC, Yen W, Mauldin EA, et al. Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment. NPJ Breast Cancer 2024:10:86.","DOI":"10.1038\/s41523-024-00690-y"},{"key":"3529_CR65","doi-asserted-by":"publisher","first-page":"eaaz4157","DOI":"10.1126\/sciadv.aaz4157","volume":"6","author":"LE Barney","year":"2020","unstructured":"Barney LE, Hall CL, Schwartz AD, Parks AN, Sparages C, Galarza S, et al. Tumor cell-organized fibronectin maintenance of a dormant breast cancer population. Sci Adv. 2020;6:eaaz4157.","journal-title":"Sci Adv"},{"key":"3529_CR66","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1091\/mbc.12.4.863","volume":"12","author":"JA Aguirre-Ghiso","year":"2001","unstructured":"Aguirre-Ghiso JA, Liu D, Mignatti A, Kovalski K, Ossowski L. Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell. 2001;12:863\u201379.","journal-title":"Mol Biol Cell"},{"key":"3529_CR67","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nrc3603","volume":"13","author":"M Pickup","year":"2013","unstructured":"Pickup M, Novitskiy S, Moses HL. The roles of TGF\u03b2 in the tumour microenvironment. Nat Rev Cancer. 2013;13:788\u201399.","journal-title":"Nat Rev Cancer"},{"key":"3529_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27220-9","volume":"12","author":"PM Munne","year":"2021","unstructured":"Munne PM, Martikainen L, R\u00e4ty I, Bertula K, Nonappa, Ruuska J, et al. Compressive stress-mediated p38 activation required for ER\u03b1\u2009+\u2009phenotype in breast cancer. Nat Commun. 2021;12:6967.","journal-title":"Nat Commun"},{"key":"3529_CR69","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1158\/0008-5472.CAN-08-3820","volume":"69","author":"AP Adam","year":"2009","unstructured":"Adam AP, George A, Schewe D, Bragado P, Iglesias BV, Ranganathan AC, et al. Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res. 2009;69:5664\u201372.","journal-title":"Cancer Res"},{"key":"3529_CR70","doi-asserted-by":"publisher","first-page":"7336","DOI":"10.1158\/0008-5472.CAN-04-0113","volume":"64","author":"JA Aguirre-Ghiso","year":"2004","unstructured":"Aguirre-Ghiso JA, Ossowski L, Rosenbaum SK. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res. 2004;64:7336\u201345.","journal-title":"Cancer Res"},{"key":"3529_CR71","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcancer.2017.03.006","volume":"44","author":"J Dittmer","year":"2017","unstructured":"Dittmer J. Mechanisms governing metastatic dormancy in breast cancer. Semin Cancer Biol. 2017;44:72\u201382.","journal-title":"Semin Cancer Biol"},{"key":"3529_CR72","doi-asserted-by":"publisher","first-page":"e32106","DOI":"10.1016\/j.heliyon.2024.e32106","volume":"10","author":"Y Dong","year":"2024","unstructured":"Dong Y, Bai J, Zhou J. Developing a dormancy-associated ECM signature in TNBC that is linked to immunosuppressive tumor microenvironment and selective sensitivity to MAPK inhibitors. Heliyon. 2024;10:e32106.","journal-title":"Heliyon"},{"key":"3529_CR73","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ccr.2004.06.025","volume":"6","author":"DE White","year":"2004","unstructured":"White DE, Kurpios NA, Zuo D, Hassell JA, Blaess S, Mueller U, et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell. 2004;6:159\u201370.","journal-title":"Cancer Cell"},{"key":"3529_CR74","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.137.1.231","volume":"137","author":"VM Weaver","year":"1997","unstructured":"Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol. 1997;137:231\u201345.","journal-title":"J Cell Biol"},{"key":"3529_CR75","doi-asserted-by":"publisher","first-page":"14821","DOI":"10.1073\/pnas.95.25.14821","volume":"95","author":"F Wang","year":"1998","unstructured":"Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc Natl Acad Sci USA. 1998;95:14821\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3529_CR76","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.matbio.2013.10.011","volume":"34","author":"P Moreno-Layseca","year":"2014","unstructured":"Moreno-Layseca P, Streuli CH. Signalling pathways linking integrins with cell cycle progression. Matrix Biol. 2014;34:144\u201353.","journal-title":"Matrix Biol"},{"key":"3529_CR77","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-07-6849","volume":"68","author":"D Barkan","year":"2008","unstructured":"Barkan D, Kleinman H, Simmons JL, Asmussen H, Kamaraju AK, Hoenorhoff MJ, et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 2008;68:6241\u201350.","journal-title":"Cancer Res"},{"key":"3529_CR78","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.1073\/pnas.0904227106","volume":"106","author":"T Shibue","year":"2009","unstructured":"Shibue T, Weinberg RA. Integrin-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci. 2009;106:10290\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"3529_CR79","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","volume":"1833","author":"P Paoli","year":"2013","unstructured":"Paoli P, Giannoni E, Chiarugi P. Anoikis molecular pathways and its role in cancer progression. Biochimica et biophysica acta. 2013;1833:3481\u201398.","journal-title":"Biochimica et biophysica acta"},{"key":"3529_CR80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/jcp.10375","volume":"198","author":"N Normanno","year":"2004","unstructured":"Normanno N, De Luca A, Bianco C, Maiello MR, Carriero MV, Rehman A, et al. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells. J Cell Physiol. 2004;198:31\u20139.","journal-title":"J Cell Physiol"},{"key":"3529_CR81","doi-asserted-by":"publisher","first-page":"626577","DOI":"10.3389\/fonc.2021.626577","volume":"11","author":"FO Adeshakin","year":"2021","unstructured":"Adeshakin FO, Adeshakin AO, Afolabi LO, Yan D, Zhang G, Wan X. Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol. 2021;11:626577.","journal-title":"Front Oncol"},{"key":"3529_CR82","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1158\/0008-5472.CAN-05-3071","volume":"66","author":"CC Park","year":"2006","unstructured":"Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res. 2006;66:1526\u201335.","journal-title":"Cancer Res"},{"key":"3529_CR83","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jbo.2012.11.002","volume":"2","author":"Y Zheng","year":"2013","unstructured":"Zheng Y, Zhou H, Dunstan CR, Sutherland RL, Seibel MJ. The role of the bone microenvironment in skeletal metastasis. J Bone Oncol. 2013;2:47\u201357.","journal-title":"J Bone Oncol"},{"key":"3529_CR84","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41392-023-01453-0","volume":"8","author":"C Li","year":"2023","unstructured":"Li C, Qiu S, Liu X, Guo F, Zhai J, Li Z, et al. Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling. Signal Transduct Target Ther. 2023;8:247.","journal-title":"Signal Transduct Target Ther"},{"key":"3529_CR85","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bbamcr.2015.05.036","volume":"1863","author":"GL Semenza","year":"2016","unstructured":"Semenza GL. The hypoxic tumor microenvironment: A driving force for breast cancer progression. Biochimica et Biophysica Acta (BBA) - Mol Cell Res. 2016;1863:382\u201391.","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Cell Res"},{"key":"3529_CR86","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13046-019-1110-6","volume":"38","author":"NI Nissen","year":"2019","unstructured":"Nissen NI, Karsdal M, Willumsen N. Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology. J Exp Clin Cancer Res. 2019;38:115.","journal-title":"J Exp Clin Cancer Res"},{"key":"3529_CR87","doi-asserted-by":"publisher","first-page":"101681","DOI":"10.1016\/j.tranon.2023.101681","volume":"33","author":"L Jingyuan","year":"2023","unstructured":"Jingyuan L, Yu L, Hong J, Tao W, Kan L, Xiaomei L, et al. Matrix stiffness induces an invasive-dormant subpopulation via cGAS-STING axis in oral cancer. Transl Oncol. 2023;33:101681.","journal-title":"Transl Oncol"},{"key":"3529_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-02992-w","volume":"23","author":"S Safaei","year":"2023","unstructured":"Safaei S, Sajed R, Shariftabrizi A, Dorafshan S, Saeednejad Zanjani L, Dehghan Manshadi M, et al. Tumor matrix stiffness provides fertile soil for cancer stem cells. Cancer Cell Int. 2023;23:143.","journal-title":"Cancer Cell Int"},{"key":"3529_CR89","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1158\/0008-5472.CAN-17-3719","volume":"78","author":"Y Liu","year":"2018","unstructured":"Liu Y, Lv J, Liang X, Yin X, Zhang L, Chen D, et al. Fibrin stiffness mediates dormancy of tumor-repopulating cells via a Cdc42-driven Tet2 epigenetic program. Cancer Res. 2018;78:3926\u201337.","journal-title":"Cancer Res"},{"key":"3529_CR90","doi-asserted-by":"publisher","first-page":"5277","DOI":"10.1158\/0008-5472.CAN-16-0579","volume":"76","author":"M-F Pang","year":"2016","unstructured":"Pang M-F, Siedlik MJ, Han S, Stallings-Mann M, Radisky DC, Nelson CM. Tissue stiffness and hypoxia modulate the integrin-linked kinase ILK to control breast cancer stem-like cells. Cancer Res. 2016;76:5277\u201387.","journal-title":"Cancer Res"},{"key":"3529_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109293","volume":"35","author":"AW Watson","year":"2021","unstructured":"Watson AW, Grant AD, Parker SS, Hill S, Whalen MB, Chakrabarti J, et al. Breast tumor stiffness instructs bone metastasis via maintenance of mechanical conditioning. Cell Rep. 2021;35:109293.","journal-title":"Cell Rep"},{"key":"3529_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/srep05512","volume":"4","author":"J Fenner","year":"2014","unstructured":"Fenner J, Stacer AC, Winterroth F, Johnson TD, Luker KE, Luker GD. Macroscopic stiffness of breast tumors predicts metastasis. Sci Rep. 2014;4:5512.","journal-title":"Sci Rep"},{"key":"3529_CR93","doi-asserted-by":"publisher","first-page":"a041331","DOI":"10.1101\/cshperspect.a041331","volume":"13","author":"E Dalla","year":"2023","unstructured":"Dalla E, Sreekumar A, Aguirre-Ghiso JA, Chodosh LA. Dormancy in breast cancer. Cold Spring Harb Perspect Med. 2023;13:a041331.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3529_CR94","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2159-8290.CD-24-0282","volume":"14","author":"A Llinas-Bertran","year":"2024","unstructured":"Llinas-Bertran A, Bellet-Ezquerra M, Seoane JA. Epigenetic control of cancer cell dormancy and awakening in endocrine therapy resistance. Cancer Discov. 2024;14:704\u20136.","journal-title":"Cancer Discov"},{"key":"3529_CR95","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1038\/s41388-021-01931-1","volume":"40","author":"ME Clements","year":"2021","unstructured":"Clements ME, Holtslander L, Edwards C, Todd V, Dooyema SDR, Bullock K, et al. HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer. Oncogene. 2021;40:5314\u201326.","journal-title":"Oncogene"},{"key":"3529_CR96","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1158\/1078-0432.CCR-20-0269","volume":"26","author":"RA Hampsch","year":"2020","unstructured":"Hampsch RA, Wells JD, Traphagen NA, McCleery CF, Fields JL, Shee K, et al. AMPK activation by metformin promotes survival of dormant ER+ breast cancer cells. Clin Cancer Res. 2020;26:3707\u201319.","journal-title":"Clin Cancer Res"},{"key":"3529_CR97","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2018.06.002","volume":"432","author":"G Natale","year":"2018","unstructured":"Natale G, Bocci G. Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data. Cancer Lett. 2018;432:28\u201337.","journal-title":"Cancer Lett"},{"key":"3529_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102754","volume":"63","author":"H Jiang","year":"2023","unstructured":"Jiang H, Zuo J, Li B, Chen R, Luo K, Xiang X, et al. Drug-induced oxidative stress in cancer treatments: Angel or devil?. Redox Biol. 2023;63:102754.","journal-title":"Redox Biol"},{"key":"3529_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11721-9","volume":"10","author":"SP Hong","year":"2019","unstructured":"Hong SP, Chan TE, Lombardo Y, Corleone G, Rotmensz N, Bravaccini S, et al. Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy. Nat Commun. 2019;10:3840.","journal-title":"Nat Commun"},{"key":"3529_CR100","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/genes11040467","volume":"11","author":"L Lanceta","year":"2020","unstructured":"Lanceta L, O\u2019Neill C, Lypova N, Li X, Rouchka E, Waigel S, et al. Transcriptomic profiling identifies differentially expressed genes in palbociclib-resistant ER+ MCF7 breast cancer cells. Genes (Basel). 2020;11:467.","journal-title":"Genes (Basel)"},{"key":"3529_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112560","volume":"42","author":"DK Singh","year":"2023","unstructured":"Singh DK, Carcamo S, Farias EF, Hasson D, Zheng W, Sun D, et al. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-\u03b2-SMAD4 signaling. Cell Rep. 2023;42:112560.","journal-title":"Cell Rep"},{"key":"3529_CR102","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(15)00613-0","volume":"17","author":"M Cristofanilli","year":"2016","unstructured":"Cristofanilli M, Turner NC, Bondarenko I, Ro J, Im SA, Masuda N, et al. Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial. Lancet Oncol. 2016;17:425\u201339.","journal-title":"Lancet Oncol"},{"key":"3529_CR103","doi-asserted-by":"publisher","first-page":"eaav0936","DOI":"10.1126\/scitranslmed.aav0936","volume":"11","author":"GV Echeverria","year":"2019","unstructured":"Echeverria GV, Ge Z, Seth S, Zhang X, Jeter-Jones S, Zhou X, et al. Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state. Sci Transl Med. 2019;11:eaav0936.","journal-title":"Sci Transl Med"},{"key":"3529_CR104","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","volume":"173","author":"C Kim","year":"2018","unstructured":"Kim C, Gao R, Sei E, Brandt R, Hartman J, Hatschek T, et al. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell. 2018;173:879\u2013893.e13.","journal-title":"Cell"},{"key":"3529_CR105","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature15748","volume":"527","author":"KR Fischer","year":"2015","unstructured":"Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527:472\u20136.","journal-title":"Nature"},{"key":"3529_CR106","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trecan.2018.10.010","volume":"5","author":"C Prunier","year":"2019","unstructured":"Prunier C, Baker D, ten Dijke P, Ritsma L. TGF-b2; Family signaling pathways in cellular dormancy,. Trends Cancer. 2019;5:66\u201378.","journal-title":"Trends Cancer"},{"key":"3529_CR107","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1158\/2159-8290.CD-23-1161","volume":"14","author":"D Rosano","year":"2024","unstructured":"Rosano D, Sofyali E, Dhiman H, Ghirardi C, Ivanoiu D, Heide T, et al. Long-term multimodal recording reveals epigenetic adaptation routes in dormant breast cancer cells. Cancer Discov. 2024;14:866\u201389.","journal-title":"Cancer Discov"},{"key":"3529_CR108","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1158\/0008-5472.CAN-05-3092","volume":"66","author":"AC Ranganathan","year":"2006","unstructured":"Ranganathan AC, Zhang L, Adam AP, Aguirre-Ghiso JA. Functional coupling of p38-induced Up-regulation of BiP and activation of RNA-dependent protein kinase\u2013like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res. 2006;66:1702\u201311.","journal-title":"Cancer Res"},{"key":"3529_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7170","volume":"6","author":"MS Sosa","year":"2015","unstructured":"Sosa MS, Parikh F, Maia AG, Estrada Y, Bosch A, Bragado P, et al. NR2F1 controls tumour cell dormancy via SOX9- and RAR\u03b2-driven quiescence programmes. Nat Commun. 2015;6:6170.","journal-title":"Nat Commun"},{"key":"3529_CR110","doi-asserted-by":"publisher","first-page":"729","DOI":"10.4161\/cbt.5.7.2968","volume":"5","author":"AC Ranganathan","year":"2006","unstructured":"Ranganathan AC, Adam AP, Zhang L, Aguirre-Ghiso JA. Tumor cell dormancy induced by p38SAPK and ER-stress signaling: an adaptive advantage for metastatic cells?. Cancer Biol Ther. 2006;5:729\u201335.","journal-title":"Cancer Biol Ther"},{"key":"3529_CR111","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nrc2256","volume":"7","author":"JA Aguirre-Ghiso","year":"2007","unstructured":"Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007;7:834\u201346.","journal-title":"Nat Rev Cancer"},{"key":"3529_CR112","first-page":"43","volume":"5","author":"AB Flynn","year":"2019","unstructured":"Flynn AB, Schiemann WP. Autophagy in breast cancer metastatic dormancy: Tumor suppressing or tumor promoting functions?. J Cancer Metastasis Treat. 2019;5:43.","journal-title":"J Cancer Metastasis Treat"},{"key":"3529_CR113","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ccell.2019.12.006","volume":"37","author":"KJ Kurppa","year":"2020","unstructured":"Kurppa KJ, Liu Y, To C, Zhang T, Fan M, Vajdi A, et al. Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway. Cancer Cell. 2020;37:104\u2013122.e12.","journal-title":"Cancer Cell"},{"key":"3529_CR114","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.tcb.2022.11.010","volume":"33","author":"H Lu","year":"2023","unstructured":"Lu H, Yang M, Zhou Q. Reprogramming transcription after DNA damage: recognition, response, repair, and restart. Trends Cell Biol. 2023;33:682\u201394.","journal-title":"Trends Cell Biol"},{"key":"3529_CR115","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cord\u00f3n-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537\u201349.","journal-title":"Cancer Cell"},{"key":"3529_CR116","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/415530a","volume":"415","author":"LJ van \u2018t Veer","year":"2002","unstructured":"van \u2018t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AAM, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530\u20136.","journal-title":"Nature"},{"key":"3529_CR117","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1158\/1078-0432.CCR-13-0838","volume":"19","author":"XHF Zhang","year":"2013","unstructured":"Zhang XHF, Giuliano M, Trivedi MV, Schiff R, Osborne CK. Metastasis dormancy in estrogen receptor\u2013positive breast cancer. Clin Cancer Res. 2013;19:6389\u201397.","journal-title":"Clin Cancer Res"},{"key":"3529_CR118","doi-asserted-by":"publisher","first-page":"e33788","DOI":"10.1371\/journal.pone.0033788","volume":"7","author":"AA Powell","year":"2012","unstructured":"Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One. 2012;7:e33788.","journal-title":"PLoS One"},{"key":"3529_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00165-4","volume":"5","author":"A Li","year":"2021","unstructured":"Li A, Keck JM, Parmar S, Patterson J, Labrie M, Creason AL, et al. Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics. npj Precis Oncol. 2021;5:28.","journal-title":"npj Precis Oncol"},{"key":"3529_CR120","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.molcel.2018.11.020","volume":"73","author":"SG Swygert","year":"2019","unstructured":"Swygert SG, Kim S, Wu X, Fu T, Hsieh T-H, Rando OJ, et al. Condensin-dependent chromatin compaction represses transcription globally during quiescence. Mol Cell. 2019;73:533\u2013546.e4.","journal-title":"Mol Cell"},{"key":"3529_CR121","doi-asserted-by":"publisher","first-page":"e1003854","DOI":"10.1371\/journal.pgen.1003854","volume":"9","author":"S Miles","year":"2013","unstructured":"Miles S, Li L, Davison J, Breeden LL. Xbp1 directs global repression of budding yeast transcription during the transition to quiescence and is important for the longevity and reversibility of the quiescent state. PLoS Genet. 2013;9:e1003854.","journal-title":"PLoS Genet"},{"key":"3529_CR122","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.molcel.2015.07.014","volume":"59","author":"JN McKnight","year":"2015","unstructured":"McKnight JN, Boerma JW, Breeden LL, Tsukiyama T. GloBal Promoter Targeting Of A Conserved Lysine Deacetylase For Transcriptional Shutoff During Quiescence Entry. Mol Cell. 2015;59:732\u201343.","journal-title":"Mol Cell"},{"key":"3529_CR123","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147:728\u201341.","journal-title":"Cell"},{"key":"3529_CR124","doi-asserted-by":"publisher","first-page":"224","DOI":"10.5306\/wjco.v5.i3.224","volume":"5","author":"P Maycotte","year":"2014","unstructured":"Maycotte P. A. Thorburn, Targeting autophagy in breast cancer. World J Clin Oncol. 2014;5:224\u201340.","journal-title":"World J Clin Oncol"},{"key":"3529_CR125","doi-asserted-by":"publisher","first-page":"22113","DOI":"10.18632\/oncotarget.25197","volume":"9","author":"HF Aqbi","year":"2018","unstructured":"Aqbi HF, Tyutyunyk-Massey L, Keim RC, Butler SE, Thekkudan T, Joshi S, et al. Autophagy-deficient breast cancer shows early tumor recurrence and escape from dormancy. Oncotarget. 2018;9:22113\u201322.","journal-title":"Oncotarget"},{"key":"3529_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11640-9","volume":"10","author":"A La Belle Flynn","year":"2019","unstructured":"La Belle Flynn A, Calhoun BC, Sharma A, Chang JC, Almasan A, Schiemann WP. Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression. Nat Commun. 2019;10:3668.","journal-title":"Nat Commun"},{"key":"3529_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04070-6","volume":"9","author":"L Vera-Ramirez","year":"2018","unstructured":"Vera-Ramirez L, Vodnala SK, Nini R, Hunter KW, Green JE. Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence. Nat Commun. 2018;9:1944.","journal-title":"Nat Commun"},{"key":"3529_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-024-01878-7","volume":"26","author":"S Dwyer","year":"2024","unstructured":"Dwyer S, Ruth J, Seidel HE, Raz AA, Chodosh LA. Autophagy is required for mammary tumor recurrence by promoting dormant tumor cell survival following therapy. Breast Cancer Res. 2024;26:143.","journal-title":"Breast Cancer Res"},{"key":"3529_CR129","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1038\/onc.2012.512","volume":"32","author":"A Avivar-Valderas","year":"2013","unstructured":"Avivar-Valderas A, Bobrovnikova-Marjon E, Alan Diehl J, Bardeesy N, Debnath J, Aguirre-Ghiso JA. Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK. Oncogene. 2013;32:4932\u201340.","journal-title":"Oncogene"},{"key":"3529_CR130","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/cdd.2008.84","volume":"15","author":"I Papandreou","year":"2008","unstructured":"Papandreou I, Lim AL, Laderoute K, Denko NC. Hypoxia signals autophagy in tumor cells via AMPK activity, independent of HIF-1, BNIP3, and BNIP3L. Cell Death Differ. 2008;15:1572\u201381.","journal-title":"Cell Death Differ"},{"key":"3529_CR131","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14:611\u201322.","journal-title":"Nat Rev Cancer"},{"key":"3529_CR132","doi-asserted-by":"publisher","first-page":"10728","DOI":"10.18632\/oncotarget.3828","volume":"6","author":"M Peiris-Pag\u00e8s","year":"2015","unstructured":"Peiris-Pag\u00e8s M, Sotgia F, Lisanti MP. Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells. Oncotarget. 2015;6:10728\u201345.","journal-title":"Oncotarget"},{"key":"3529_CR133","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.1087782","volume":"301","author":"A Mel\u00e9ndez","year":"2003","unstructured":"Mel\u00e9ndez A, Tall\u00f3czy Z, Seaman M, Eskelinen E-L, Hall DH, Levine B. Autophagy genes are essential for Dauer development and life-span extension in C. elegans. Science. 2003;301:1387\u201391.","journal-title":"Science"},{"key":"3529_CR134","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.1016\/j.annonc.2023.09.442","volume":"34","author":"A DeMichele","year":"2023","unstructured":"DeMichele A, Clark AS, Bayne L, Rohn K, Nivar I, Wileyto P, et al. 244MO A phase II trial targeting disseminated dormant tumor cells with hydroxychloroquine, everolimus or the combination to prevent recurrent breast cancer. Ann Oncol. 2023;34:S281.","journal-title":"Ann Oncol"},{"key":"3529_CR135","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/B:BREA.0000004377.12288.3c","volume":"82","author":"GN Naumov","year":"2003","unstructured":"Naumov GN, Townson JL, MacDonald IC, Wilson SM, Bramwell VHC, Groom AC, et al. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat. 2003;82:199\u2013206.","journal-title":"Breast Cancer Res Treat"},{"key":"3529_CR136","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2020.01.008","volume":"474","author":"E Abad","year":"2020","unstructured":"Abad E, Graifer D, Lyakhovich A. DNA damage response and resistance of cancer stem cells. Cancer Lett. 2020;474:106\u201317.","journal-title":"Cancer Lett"},{"key":"3529_CR137","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.canlet.2016.04.002","volume":"376","author":"DH Liang","year":"2016","unstructured":"Liang DH, Choi DS, Ensor JE, Kaipparettu BA, Bass BL, Chang JC. The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair. Cancer Lett. 2016;376:249\u201358.","journal-title":"Cancer Lett"},{"key":"3529_CR138","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5306\/wjco.v6.i5.80","volume":"6","author":"EB Evans","year":"2015","unstructured":"Evans EB, Lin SY. New insights into tumor dormancy: targeting DNA repair pathways. World J Clin Oncol. 2015;6:80\u20138.","journal-title":"World J Clin Oncol"},{"key":"3529_CR139","doi-asserted-by":"publisher","first-page":"100017","DOI":"10.1016\/j.crphar.2021.100017","volume":"2","author":"FM Barnieh","year":"2021","unstructured":"Barnieh FM, Loadman PM, Falconer RA. Progress towards a clinically-successful ATR inhibitor for cancer therapy. Curr Res Pharm Drug Discov. 2021;2:100017.","journal-title":"Curr Res Pharm Drug Discov"},{"key":"3529_CR140","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molonc.2015.09.009","volume":"10","author":"N Alsubhi","year":"2016","unstructured":"Alsubhi N, Middleton F, Abdel-Fatah TMA, Stephens P, Doherty R, Arora A, et al. Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio-resistance in breast cancer. Mol Oncol. 2016;10:213\u201323.","journal-title":"Mol Oncol"},{"key":"3529_CR141","doi-asserted-by":"publisher","first-page":"41677","DOI":"10.18632\/oncotarget.9528","volume":"7","author":"M Bredemeier","year":"2016","unstructured":"Bredemeier M, Edimiris P, Tewes M, Mach P, Aktas B, Schellbach D, et al. Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment. Oncotarget. 2016;7:41677\u201390.","journal-title":"Oncotarget"},{"key":"3529_CR142","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1158\/1078-0432.CCR-15-1348","volume":"23","author":"YJ Liu","year":"2017","unstructured":"Liu YJ, Burness ML, Martin-Trevino R, Guy J, Bai SM, Harouaka R, et al. RAD51 mediates resistance of cancer stem cells to PARP inhibition in triple-negative breast cancer. Clin Cancer Res. 2017;23:514\u201322.","journal-title":"Clin Cancer Res"},{"key":"3529_CR143","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","volume":"384","author":"ANJ Tutt","year":"2021","unstructured":"Tutt ANJ, Garber JE, Kaufman B, Viale G, Fumagalli D, Rastogi P, et al. Adjuvant olaparib for patients with BRCA1 or BRCA2-mutated breast cancer. N Engl J Med. 2021;384:2394\u2013405.","journal-title":"N Engl J Med"},{"key":"3529_CR144","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.jtho.2021.07.017","volume":"16","author":"M Mikubo","year":"2021","unstructured":"Mikubo M, Inoue Y, Liu G, Tsao M-S. Mechanism of drug tolerant persister cancer cells: the landscape and clinical implication for therapy. J Thorac Oncol. 2021;16:1798\u2013809.","journal-title":"J Thorac Oncol"},{"key":"3529_CR145","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.3390\/cells10102707","volume":"10","author":"B Li","year":"2021","unstructured":"Li B, Huang Y, Ming H, Nice EC, Xuan R, Huang C. Redox control of the dormant cancer cell life cycle. Cells. 2021;10:2707.","journal-title":"Cells"},{"key":"3529_CR146","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.tcb.2023.03.004","volume":"33","author":"SF El-Khamisy","year":"2023","unstructured":"El-Khamisy SF. Oxidative DNA damage and repair at non-coding regulatory regions. Trends Cell Biol. 2023;33:939\u201349.","journal-title":"Trends Cell Biol"},{"key":"3529_CR147","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41586-022-05217-8","volume":"609","author":"S Ray","year":"2022","unstructured":"Ray S, Abugable AA, Parker J, Liversidge K, Palminha NM, Liao C, et al. A mechanism for oxidative damage repair at gene regulatory elements. Nature. 2022;609:1038\u201347.","journal-title":"Nature"},{"key":"3529_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2721","volume":"12","author":"NG Bediaga","year":"2010","unstructured":"Bediaga NG, Acha-Sagredo A, Guerra I, Viguri A, Albaina C, Ruiz Diaz I, et al. DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer Res. 2010;12:R77.","journal-title":"Breast Cancer Res"},{"key":"3529_CR149","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.molcel.2013.02.013","volume":"49","author":"JA Simon","year":"2013","unstructured":"Simon JA, Kingston RE. Occupying chromatin: polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell. 2013;49:808\u201324.","journal-title":"Mol Cell"},{"key":"3529_CR150","doi-asserted-by":"publisher","first-page":"1421629","DOI":"10.3389\/fcell.2024.1421629","volume":"12","author":"AL Capatina","year":"2024","unstructured":"Capatina AL, Malcolm JR, Stenning J, Moore RL, Bridge KS, Brackenbury WJ, et al. Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment. Front Cell Dev Biol. 2024;12:1421629.","journal-title":"Front Cell Dev Biol"},{"key":"3529_CR151","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/stem.1746","volume":"32","author":"DS Choi","year":"2014","unstructured":"Choi DS, Blanco E, Kim Y-S, Rodriguez AA, Zhao H, Huang TH-M, et al. Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1. Stem Cells. 2014;32:2309\u201323.","journal-title":"Stem Cells"},{"key":"3529_CR152","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrclinonc.2016.144","volume":"14","author":"M Mohme","year":"2017","unstructured":"Mohme M, Riethdorf S, Pantel K. Circulating and disseminated tumour cells \u2014 mechanisms of immune surveillance and escape. Nat Rev Clin Oncol. 2017;14:155\u201367.","journal-title":"Nat Rev Clin Oncol"},{"key":"3529_CR153","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"3529_CR154","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nm.2830","volume":"18","author":"BN Bidwell","year":"2012","unstructured":"Bidwell BN, Slaney CY, Withana NP, Forster S, Cao Y, Loi S, et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med. 2012;18:1224\u201331.","journal-title":"Nat Med"},{"key":"3529_CR155","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1158\/0008-5472.CAN-13-0992","volume":"74","author":"IB Barsoum","year":"2014","unstructured":"Barsoum IB, Smallwood CA, Siemens DR, Graham CH. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res. 2014;74:665\u201374.","journal-title":"Cancer Res"},{"key":"3529_CR156","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/s41388-018-0624-2","volume":"38","author":"Q Lan","year":"2019","unstructured":"Lan Q, Peyvandi S, Duffey N, Huang Y-T, Barras D, Held W, et al. Type I interferon\/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer. Oncogene. 2019;38:2814\u201329.","journal-title":"Oncogene"},{"key":"3529_CR157","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1158\/1078-0432.CCR-15-1434","volume":"22","author":"Y Lou","year":"2016","unstructured":"Lou Y, Diao L, Cuentas ER, Denning WL, Chen L, Fan YH, et al. Epithelial-mesenchymal transition is associated with a distinct tumor microenvironment including elevation of inflammatory signals and multiple immune checkpoints in lung adenocarcinoma. Clin Cancer Res. 2016;22:3630\u201342.","journal-title":"Clin Cancer Res"},{"key":"3529_CR158","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","volume":"185","author":"P Baldominos","year":"2022","unstructured":"Baldominos P, Barbera-Mourelle A, Barreiro O, Huang Y, Wight A, Cho J-W, et al. Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell. 2022;185:1694\u20131708.e19.","journal-title":"Cell"},{"key":"3529_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28438-x","volume":"13","author":"M Qi","year":"2022","unstructured":"Qi M, Xia Y, Wu Y, Zhang Z, Wang X, Lu L, et al. Lin28B-high breast cancer cells promote immune suppression in the lung pre-metastatic niche via exosomes and support cancer progression. Nat Commun. 2022;13:897.","journal-title":"Nat Commun"},{"key":"3529_CR160","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.molonc.2015.05.009","volume":"9","author":"M Mazel","year":"2015","unstructured":"Mazel M, Jacot W, Pantel K, Bartkowiak K, Topart D, Cayrefourcq L, et al. Frequent expression of PD-L1 on circulating breast cancer cells. Mol Oncol. 2015;9:1773\u201382.","journal-title":"Mol Oncol"},{"key":"3529_CR161","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/cancers15010104","volume":"15","author":"X Chen","year":"2022","unstructured":"Chen X, Feng L, Huang Y, Wu Y, Xie N. Mechanisms and strategies to overcome PD-1\/PD-L1 blockade resistance in triple-negative breast cancer. Cancers (Basel). 2022;15:104.","journal-title":"Cancers (Basel)"},{"key":"3529_CR162","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","volume":"165","author":"S Malladi","year":"2016","unstructured":"Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, et al. Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell. 2016;165:45\u201360.","journal-title":"Cell"},{"key":"3529_CR163","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/2159-8290.CD-12-0329","volume":"2","author":"M Labelle","year":"2012","unstructured":"Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2012;2:1091\u20139.","journal-title":"Cancer Discov"},{"key":"3529_CR164","doi-asserted-by":"publisher","first-page":"100244","DOI":"10.1016\/j.jbo.2019.100244","volume":"17","author":"G Allocca","year":"2019","unstructured":"Allocca G, Hughes R, Wang N, Brown HK, Ottewell PD, et al. The bone metastasis niche in breast cancer-potential overlap with the haematopoietic stem cell niche in vivo. J Bone Oncol. 2019;17:100244.","journal-title":"J Bone Oncol"},{"key":"3529_CR165","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41556-022-00881-4","volume":"24","author":"SB Crist","year":"2022","unstructured":"Crist SB, Nemkov T, Dumpit RF, Dai J, Tapscott SJ, True LD, et al. Unchecked oxidative stress in skeletal muscle prevents outgrowth of disseminated tumour cells. Nat Cell Biol. 2022;24:538\u201353.","journal-title":"Nat Cell Biol"},{"key":"3529_CR166","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1016\/j.cell.2024.09.016","volume":"187","author":"E Dalla","year":"2024","unstructured":"Dalla E, Papanicolaou M, Park MD, Barth N, Hou R, Segura-Villalobos D, et al. Lung-resident alveolar macrophages regulate the timing of breast cancer metastasis. Cell. 2024;187:6631\u20136648.e20.","journal-title":"Cell"},{"key":"3529_CR167","doi-asserted-by":"publisher","first-page":"16121","DOI":"10.1073\/pnas.1305937110","volume":"110","author":"G Ghiaur","year":"2013","unstructured":"Ghiaur G, Yegnasubramanian S, Perkins B, Gucwa JL, Gerber JM, Jones RJ. Regulation of human hematopoietic stem cell self-renewal by the microenvironment\u2019s control of retinoic acid signaling. Proc Natl Acad Sci USA. 2013;110:16121\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3529_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00269-x","volume":"7","author":"GG Bushnell","year":"2021","unstructured":"Bushnell GG, Deshmukh AP, den Hollander P, Luo M, Soundararajan R, Jia D, et al. Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge. npj Breast Cancer. 2021;7:66.","journal-title":"npj Breast Cancer"},{"key":"3529_CR169","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s43018-020-0088-5","volume":"1","author":"E Risson","year":"2020","unstructured":"Risson E, Nobre AR, Maguer-Satta V, Aguirre-Ghiso JA. The current paradigm and challenges ahead for the dormancy of disseminated tumor cells. Nat Cancer. 2020;1:672\u201380.","journal-title":"Nat Cancer"},{"key":"3529_CR170","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.tcb.2022.03.007","volume":"32","author":"C Jehanno","year":"2022","unstructured":"Jehanno C, Vulin M, Richina V, Richina F, Bentires-Alj M. Phenotypic plasticity during metastatic colonization. Trends Cell Biol. 2022;32:854\u201367.","journal-title":"Trends Cell Biol"},{"key":"3529_CR171","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2013.10.029","volume":"155","author":"FG Giancotti","year":"2013","unstructured":"Giancotti FG. Mechanisms governing metastatic dormancy and reactivation. Cell. 2013;155:750\u201364.","journal-title":"Cell"},{"key":"3529_CR172","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1200\/JCO.2009.21.9782","volume":"27","author":"SW Cole","year":"2009","unstructured":"Cole SW. Chronic inflammation and breast cancer recurrence. J Clin Oncol. 2009;27:3418\u20139.","journal-title":"J Clin Oncol"},{"key":"3529_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0259-5","volume":"16","author":"S Tivari","year":"2018","unstructured":"Tivari S, Lu H, Dasgupta T, De Lorenzo MS, Wieder R. Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence. Cell Commun Signal. 2018;16:48.","journal-title":"Cell Commun Signal"},{"key":"3529_CR174","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4227","volume":"361","author":"J Albrengues","year":"2018","unstructured":"Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018;361:eaao4227.","journal-title":"Science"},{"key":"3529_CR175","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/0008-5472.CAN-14-3587","volume":"75","author":"R Hughes","year":"2015","unstructured":"Hughes R, Qian BZ, Rowan C, Muthana M, Keklikoglou I, Olson OC, et al. Perivascular M2 macrophages stimulate tumor relapse after chemotherapy. Cancer Res. 2015;75:3479\u201391.","journal-title":"Cancer Res"},{"key":"3529_CR176","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s43018-023-00525-y","volume":"4","author":"FK Turrell","year":"2023","unstructured":"Turrell FK, Orha R, Guppy NJ, Gillespie A, Guelbert M, Starling C, et al. Age-associated microenvironmental changes highlight the role of PDGF-C in ER+ breast cancer metastatic relapse. Nat Cancer. 2023;4:468\u201384.","journal-title":"Nat Cancer"},{"key":"3529_CR177","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1158\/0008-5472.CAN-15-3332","volume":"76","author":"T Marsh","year":"2016","unstructured":"Marsh T, Wong I, Sceneay J, Barakat A, Qin Y, Sj\u00f6din A, et al. Hematopoietic age at onset of triple-negative breast cancer dictates disease aggressiveness and progression. Cancer Res. 2016;76:2932\u201343.","journal-title":"Cancer Res"},{"key":"3529_CR178","doi-asserted-by":"publisher","first-page":"e125679","DOI":"10.1172\/jci.insight.125679","volume":"4","author":"A Singh","year":"2019","unstructured":"Singh A, Veeriah V, Xi P, Labella R, Chen J, Romeo SG, et al. Angiocrine signals regulate quiescence and therapy resistance in bone metastasis. JCI Insight. 2019;4:e125679.","journal-title":"JCI Insight"},{"key":"3529_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18701-4","volume":"11","author":"M Werner-Klein","year":"2020","unstructured":"Werner-Klein M, Grujovic A, Irlbeck C, Obradovi\u0107 M, Hoffmann M, Koerkel-Qu H, et al. Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency. Nat Commun. 2020;11:4977.","journal-title":"Nat Commun"},{"key":"3529_CR180","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1530\/ERC-16-0086","volume":"23","author":"HH Han","year":"2016","unstructured":"Han HH, Kim BG, Lee JH, Kang S, Kim JE, Cho NH. Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche. Endocr Relat Cancer. 2016;23:609\u201323.","journal-title":"Endocr Relat Cancer"},{"key":"3529_CR181","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27\u201341.","journal-title":"Immunity"},{"key":"3529_CR182","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12807-0","volume":"10","author":"R Eyre","year":"2019","unstructured":"Eyre R, Alf\u00e9rez DG, Santiago-G\u00f3mez A, Spence K, McConnell JC, Hart C, et al. Microenvironmental IL1\u03b2 promotes breast cancer metastatic colonisation in the bone via activation of Wnt signalling. Nat Commun. 2019;10:5016.","journal-title":"Nat Commun"},{"key":"3529_CR183","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl0165","volume":"10","author":"NR Richbourg","year":"2024","unstructured":"Richbourg NR, Irakoze N, Kim H, Peyton SR. Outlook and opportunities for engineered environments of breast cancer dormancy. Sci Adv. 2024;10:eadl0165.","journal-title":"Sci Adv"},{"key":"3529_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-018-0106-7","volume":"12","author":"HR Lee","year":"2018","unstructured":"Lee HR, Leslie F, Azarin SM. A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl2. J Biol Eng. 2018;12:12.","journal-title":"J Biol Eng"},{"key":"3529_CR185","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tips.2018.12.004","volume":"40","author":"A Recasens","year":"2019","unstructured":"Recasens A, Munoz L. Targeting cancer cell dormancy. Trends Pharm Sci. 2019;40:128\u201341.","journal-title":"Trends Pharm Sci"},{"key":"3529_CR186","doi-asserted-by":"publisher","first-page":"105186","DOI":"10.1016\/j.ebiom.2024.105186","volume":"105","author":"H Li","year":"2024","unstructured":"Li H, Wu Y, Zou H, Koner S, Plichta JK, Tolaney SM, et al. Clinical efficacy of CDK4\/6 inhibitor plus endocrine therapy in HR-positive\/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trials. eBioMedicine. 2024;105:105186.","journal-title":"eBioMedicine"},{"key":"3529_CR187","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s12276-020-0423-z","volume":"52","author":"S-Y Park","year":"2020","unstructured":"Park S-Y, Nam J-S. The force awakens: metastatic dormant cancer cells. Exp Mol Med. 2020;52:569\u201381.","journal-title":"Exp Mol Med"},{"key":"3529_CR188","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/nature07815","volume":"458","author":"MAG Essers","year":"2009","unstructured":"Essers MAG, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, et al. IFN\u03b1 activates dormant haematopoietic stem cells in vivo. Nature. 2009;458:904\u20138.","journal-title":"Nature"},{"key":"3529_CR189","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1607","volume":"28","author":"Y Saito","year":"2010","unstructured":"Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nat Biotechnol. 2010;28:275\u201380.","journal-title":"Nat Biotechnol"},{"key":"3529_CR190","doi-asserted-by":"publisher","first-page":"E9066","DOI":"10.1073\/pnas.1704862114","volume":"114","author":"P Sansone","year":"2017","unstructured":"Sansone P, Savini C, Kurelac I, Chang Q, Amato LB, Strillacci A, et al. Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proc Natl Acad Sci USA. 2017;114:E9066\u2013E9075.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3529_CR191","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adr3997","volume":"10","author":"S Bakhshandeh","year":"2024","unstructured":"Bakhshandeh S, Heras U, Ta\u00efeb HM, Varadarajan AR, Lissek SM, H\u00fccker SM, et al. Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis. Sci Adv. 2024;10:eadr3997.","journal-title":"Sci Adv"},{"key":"3529_CR192","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/ncb2767","volume":"15","author":"CM Ghajar","year":"2013","unstructured":"Ghajar CM, Peinado H, Mori H, Matei IR, Evason KJ, Brazier H, et al. The perivascular niche regulates breast tumour dormancy. Nat Cell Biol. 2013;15:807\u201317.","journal-title":"Nat Cell Biol"},{"key":"3529_CR193","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1172\/JCI70259","volume":"124","author":"LH El Touny","year":"2014","unstructured":"El Touny LH, Vieira A, Mendoza A, Khanna C, Hoenerhoff MJ, Green JE. Combined SFK\/MEK inhibition prevents metastatic outgrowth of dormant tumor cells. J Clin Invest. 2014;124:156\u201368.","journal-title":"J Clin Invest"},{"key":"3529_CR194","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade3186","volume":"9","author":"L Pradhan","year":"2023","unstructured":"Pradhan L, Moore D, Ovadia EM, Swedzinski SL, Cossette T, Sikes RA, et al. Dynamic bioinspired coculture model for probing ER(+) breast cancer dormancy in the bone marrow niche. Sci Adv. 2023;9:eade3186.","journal-title":"Sci Adv"},{"key":"3529_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115388","volume":"44","author":"P Pereira","year":"2025","unstructured":"Pereira P, Panier J, Nater M, Herbst M, Calvanese AL, K\u00f6ksal H, et al. Inflammatory cytokines mediate the induction of and awakening from metastatic dormancy. Cell Rep. 2025;44:115388.","journal-title":"Cell Rep"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03529-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03529-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03529-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T22:04:13Z","timestamp":1759097053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03529-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":195,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2025,10,20]]}},"alternative-id":["3529"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03529-3","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}